Method of increasing the in vivo recovery of therapeutic polypeptides

Details for Australian Patent Application No. 2007236280 (hide)

Owner CSL Behring GmbH

Inventors Schulte, Stefan; Weimer, Thomas; Lang, Wiegand; Wormsbacher, Wilfried; Metzner, Hubert

Agent Watermark

Pub. Number AU-A-2007236280

PCT Pub. Number WO2007/115724

Priority 06007552.0 11.04.06 EP

Filing date 2 April 2007

Wipo publication date 18 October 2007

International Classifications

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

C12N 15/62 (2006.01) Mutation or genetic engineering - DNA sequences coding for fusion proteins

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/115724 Priority application(s): WO2007/115724

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007236281-Value document comprising a security element

2007236269-Treatment of multiple sclerosis and/or rheumatoid arthritis